- UPDATED 9PM | AstraZeneca has announced some findings from its Phase III trial.
KINIGUIDE | As preliminary results trickle in from late-stage Covid-19 vaccine trials, Malaysia is also negotiating deals to secure enough doses to immunise its population against the disease.
The government has signed a five-year deal with China that would, among others, provide priority access to vaccines developed in China once they become available.
It is also fixing a date to sign the Optional Purchase Arrangement for the Covid-19 vaccine Global Access Facility (Covax) at the cost of a US$22.66 million (RM94.08 million) down payment.
Additionally, the Health Ministry said it is evaluating 10 out of the 11 Covid-19 vaccine candidates that are currently in Phase III clinical trials.
In this instalment of KiniGuide, we give a rundown of the vaccine candidates in the running, and how Malaysia is moving to ensure an adequate supply of the highly demanded resource.
When can I get one?
According to Health Minister Dr Adham Baba, Malaysia hopes to acquire the vaccines and make it available for use by the first quarter of next year.